» Articles » PMID: 23356818

Ethnic Differences in Atrial Fibrillation Identified Using Implanted Cardiac Devices

Abstract

Introduction: Atrial fibrillation (AF) is suggested to be less common among black and Asian individuals, which could reflect bias in symptom reporting and access to care. In the Asymptomatic AF and Stroke Evaluation in Pacemaker Patients and the AF Reduction Atrial Pacing Trial (ASSERT), patients with hypertension but no history of AF had AF recorded via an implanted pacemaker or defibrillator, thus allowing both symptomatic and asymptomatic AF incidence to be determined without ascertainment bias.

Methods And Results: The ASSERT enrolled 2,580 patients in 23 countries in North America, Europe, and Asia. AF was defined as device-recorded AF episodes >190/min, lasting either for >6 minutes or >6 hours in duration. All ethnic groups with >50 patients were enrolled. Ethnic groups studied include Europeans (n = 1900), black Africans (n = 73), Chinese (n = 89), and Japanese (n = 105) patients. Compared to Europeans, black Africans had more risk factors for AF such as heart failure (27.8 vs 14.6%) and diabetes (41.7 vs 26.3%). At 2.5 years follow-up, all 3 non-European races had a lower incidence of AF (8.3%, 10.1%, and 9.5% vs 18.0%, respectively, for AF>6 minutes, P < 0.006). When adjusted for baseline difference, Chinese had a lower incidence of AF > 6 minutes (P < 0.007), and Japanese and black Africans had a lower incidence of AF > 6 hours (P < 0.04 and P = 0.057, respectively).

Conclusions: Black Africans, Chinese, and Japanese had lower incidence of AF compared to Europeans. In the case of black Africans, this is despite an increased prevalence of AF risk factors.

Citing Articles

Ethnic Differences in Atrial Fibrillation in the United Kingdom.

Frimodt-Moller E, Tang J, Biering-Sorensen T, Delling F, Jackson 2nd L, Marcus G JACC Adv. 2025; 3(12):101043.

PMID: 39817084 PMC: 11734043. DOI: 10.1016/j.jacadv.2024.101043.


Atrial fibrillation in Black American patients: A review of genetics, risk factors, and outcomes.

Houmsse A, Malhotra N, Smith S, El Refaey M Heart Rhythm. 2024; 22(3):617-626.

PMID: 39515500 PMC: 11875954. DOI: 10.1016/j.hrthm.2024.10.074.


Atrial Fibrillation and Reperfusion Therapy in Acute Ischaemic Stroke Patients: Prevalence and Outcomes-A Comprehensive Systematic Review and Meta-Analysis.

Patel J, Bhaskar S Neurol Int. 2023; 15(3):1014-1043.

PMID: 37755356 PMC: 10537209. DOI: 10.3390/neurolint15030065.


Global Burden of Atrial Fibrillation and Flutter by National Income: Results From the Global Burden of Disease 2019 Database.

Ohlrogge A, Brederecke J, Schnabel R J Am Heart Assoc. 2023; 12(17):e030438.

PMID: 37646216 PMC: 10547346. DOI: 10.1161/JAHA.123.030438.


A nationwide analysis of the outcomes in hospitalized patients with atrial fibrillation and temperature-related illnesses.

Antwi-Amoabeng D, Sathappan S, Firzli T, Beutler B, Ulanja M, Gbadebo T Clinics (Sao Paulo). 2023; 78:100269.

PMID: 37557004 PMC: 10432905. DOI: 10.1016/j.clinsp.2023.100269.